HDAC3 and colitis: This conclusion supports a previous study, that homeodomain-interacting protein kinase 2 (HIPK2) binds and phosphorylates HDAC3 at serine 374 to inhibit its enzymatic activity and to restrain excessive inflammation, and thus may provide a new therapy for colitis 32.